AAAAAA

   
Results: 1-19 |
Results: 19
Regular ingestion of opuntia robusta lowers oxidation injury
Authors: Budinsky, A Wolfram, R Oguogho, A Efthimiou, Y Stamatopoulos, Y Sinzinger, H
Citation: A. Budinsky et al., Regular ingestion of opuntia robusta lowers oxidation injury, PROS LEUK E, 65(1), 2001, pp. 45-50
Increase of isoprostane 8-epi-PGF(2 alpha) after restarting smoking
Authors: Chehne, F Oguogho, A Lupattelli, G Budinsky, AC Palumbo, B Sinzinger, H
Citation: F. Chehne et al., Increase of isoprostane 8-epi-PGF(2 alpha) after restarting smoking, PROS LEUK E, 64(6), 2001, pp. 307-310
6-oxo-PGF(1 alpha) and 8-epi-PGF(2 alpha) in the arterial wall layers of various species: a comparison between intact and atherosclerotic areas
Authors: Oguogho, A Kritz, H Wagner, O Sinzinger, H
Citation: A. Oguogho et al., 6-oxo-PGF(1 alpha) and 8-epi-PGF(2 alpha) in the arterial wall layers of various species: a comparison between intact and atherosclerotic areas, PROS LEUK E, 64(3), 2001, pp. 167-171
Isoprostane 8-epi-PGF(2 alpha) is frequently increased in patients with muscle pain and/or CK-elevation after HMG-Co-enzyme-A-reductase inhibitor therapy
Authors: Sinzinger, H Lupattelli, G Chehne, F Oguogho, A Furberg, CD
Citation: H. Sinzinger et al., Isoprostane 8-epi-PGF(2 alpha) is frequently increased in patients with muscle pain and/or CK-elevation after HMG-Co-enzyme-A-reductase inhibitor therapy, J CLIN PH T, 26(4), 2001, pp. 303-310
LDL apheresis decreases plasma levels and urinary excretion of 8-epi-PGF(2alpha)
Authors: Oguogho, A Ferlitsch, A Sinzinger, H
Citation: A. Oguogho et al., LDL apheresis decreases plasma levels and urinary excretion of 8-epi-PGF(2alpha), PROS LEUK E, 62(4), 2000, pp. 209-216
Eicosanoid generation and responsiveness of human lymphatics in hyperlipoproteinemia
Authors: Oguogho, A Kaliman, J Sinzinger, H
Citation: A. Oguogho et al., Eicosanoid generation and responsiveness of human lymphatics in hyperlipoproteinemia, PROS LEUK E, 62(1), 2000, pp. 47-52
Isoprostanes in atherosclerosis
Authors: Oguogho, A Sinzinger, H
Citation: A. Oguogho et H. Sinzinger, Isoprostanes in atherosclerosis, J PHYSL PH, 51(4), 2000, pp. 673-682
Prostaglandin E-1-therapy reduces circulating adhesion molecules (ICAM-1, E-selectin, VCAM-1) in peripheral vascular disease
Authors: Palumbo, B Oguogho, A Fitscha, P Sinzinger, H
Citation: B. Palumbo et al., Prostaglandin E-1-therapy reduces circulating adhesion molecules (ICAM-1, E-selectin, VCAM-1) in peripheral vascular disease, VASA, 29(3), 2000, pp. 179-185
Isoprostanes quickly normalize after quitting cigarette smoking in healthyadults
Authors: Oguogho, A Lupattelli, G Palumbo, B Sinzinger, H
Citation: A. Oguogho et al., Isoprostanes quickly normalize after quitting cigarette smoking in healthyadults, VASA, 29(2), 2000, pp. 103-105
Quitting cigarette smoking results in a fast improvement of in vivo oxidation injury (determined via plasma, serum and urinary isoprostane)
Authors: Pilz, H Oguogho, A Chehne, F Lupattelli, G Palumbo, B Sinzinger, H
Citation: H. Pilz et al., Quitting cigarette smoking results in a fast improvement of in vivo oxidation injury (determined via plasma, serum and urinary isoprostane), THROMB RES, 99(3), 2000, pp. 209-221
Angiotensin receptor antagonists during dextran sulfate LDL-apheresis are safe
Authors: Sinzinger, H Chehne, F Ferlitsch, A Oguogho, A
Citation: H. Sinzinger et al., Angiotensin receptor antagonists during dextran sulfate LDL-apheresis are safe, THROMB RES, 100(1), 2000, pp. 43-46
Prostaglandin synthesis in human lymphatics from precursor fatty acids
Authors: Oguogho, A Aghajanian, AA Sinzinger, H
Citation: A. Oguogho et al., Prostaglandin synthesis in human lymphatics from precursor fatty acids, LYMPHOLOGY, 33(2), 2000, pp. 62-66
Eicosanoid production and lymphatic responsiveness in human cigarette smokers compared with nonsmokers (vol 33, pg 24, 2000)
Authors: Sinzinger, H Kaliman, J Oguogho, A
Citation: H. Sinzinger et al., Eicosanoid production and lymphatic responsiveness in human cigarette smokers compared with nonsmokers (vol 33, pg 24, 2000), LYMPHOLOGY, 33(2), 2000, pp. 75-75
Eicosanoid production and lymphatic responsiveness in human cigarette smokers compared with non-smokers
Authors: Sinzinger, H Kaliman, J Oguogho, A
Citation: H. Sinzinger et al., Eicosanoid production and lymphatic responsiveness in human cigarette smokers compared with non-smokers, LYMPHOLOGY, 33(1), 2000, pp. 24-31
6-oxo-PGF(1 alpha) and 8-epi-PGF(2 alpha) in human atherosclerotic vascular tissue
Authors: Oguogho, A Karanikas, G Kritz, H Riehs, G Wagner, O Sinzinger, H
Citation: A. Oguogho et al., 6-oxo-PGF(1 alpha) and 8-epi-PGF(2 alpha) in human atherosclerotic vascular tissue, PROS LEUK E, 60(2), 1999, pp. 129-134
Influence of prostaglandin E-1 on the endothelium platelet interaction
Authors: Sinzinger, H Palumbo, B Oguogho, A
Citation: H. Sinzinger et al., Influence of prostaglandin E-1 on the endothelium platelet interaction, VASA, 1999, pp. 5-10
Increased plasma, serum and urinary 8-epi-prostaglandin F-2 alpha in heterozygous hypercholesterolemia
Authors: Oguogho, A Mehrabi, M Sinzinger, H
Citation: A. Oguogho et al., Increased plasma, serum and urinary 8-epi-prostaglandin F-2 alpha in heterozygous hypercholesterolemia, WIEN KLIN W, 111(3), 1999, pp. 113-118
The isoprostane, 8-epi-PGF(2 alpha), is accumulated in coronary arteries isolated from patients with coronary heart disease
Authors: Mehrabi, MR Ekmekcioglu, C Tatzber, F Oguogho, A Ullrich, R Morgan, A Tamaddon, F Grimm, M Glogar, HD Sinzinger, H
Citation: Mr. Mehrabi et al., The isoprostane, 8-epi-PGF(2 alpha), is accumulated in coronary arteries isolated from patients with coronary heart disease, CARDIO RES, 43(2), 1999, pp. 492-499
Levels of eicosanoids (6-oxo-PGF(1 alpha) and 8-epi-PGF(2 alpha)) in humanand porcine lymphatics and lymph
Authors: Oguogho, A Kaliman, J Sinzinger, H
Citation: A. Oguogho et al., Levels of eicosanoids (6-oxo-PGF(1 alpha) and 8-epi-PGF(2 alpha)) in humanand porcine lymphatics and lymph, LYMPHOLOGY, 31(4), 1998, pp. 186-189
Risultati: 1-19 |